Impact of Adherence to Guideline-Recommended Diagnostic Testing on Treatment Selection and Survival in Patients with Diffuse Large B-Cell Lymphoma in the US

被引：0
|
作者：
Yang, Fei [1 ]
Abraham, Anup [2 ]
Hammer, Richard [3 ]
Prime, Matthew [1 ]
机构：
[1] Roche, Basel, Switzerland
[2] Genesis Res, Hoboken, CA USA
[3] Univ Missouri, Columbia, MO USA
来源：
MODERN PATHOLOGY | 2021年 / 34卷 / SUPPL 2期
关键词：
D O I：
暂无
中图分类号：
R36 [病理学];
学科分类号：
100104 ;
摘要：
989
引用
收藏
页码：1183 / 1183
页数：1
相关论文
共 50 条
  • [1] Impact of Adherence to Guideline-Recommended Diagnostic Testing on Treatment Selection and Survival in Patients with Diffuse Large B-Cell Lymphoma in the US
    Yang, Fei
    Abraham, Anup
    Hammer, Richard
    Prime, Matthew
    [J]. LABORATORY INVESTIGATION, 2021, 101 (SUPPL 1) : 1183 - 1183
  • [2] Socioeconomic Disparities in Diagnostic Testing Among Patients with Diffuse Large B-Cell Lymphoma in the US
    Yang, Fei
    Abraham, Anup
    Zhang, Ju
    Xiao, Yan
    Hammer, Richard D.
    Doll, Donald C.
    Prime, Matthew S.
    [J]. BLOOD, 2020, 136
  • [3] Adherence to guidelines-recommended diagnostic testing was associated with overall survival in patients with diffuse large B-cell lymphoma after rituximab-based treatment: an observational cohort study
    Yang, Fei
    Zhang, Ju
    Abraham, Anup
    Yan, Jessie T.
    Hammer, Richard D.
    Prime, Matthew S.
    [J]. JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY, 2023, 149 (07) : 3691 - 3700
  • [4] Adherence to guidelines-recommended diagnostic testing was associated with overall survival in patients with diffuse large B-cell lymphoma after rituximab-based treatment: an observational cohort study
    Fei Yang
    Ju Zhang
    Anup Abraham
    Jessie T. Yan
    Richard D. Hammer
    Matthew S. Prime
    [J]. Journal of Cancer Research and Clinical Oncology, 2023, 149 : 3691 - 3700
  • [5] Conditional survival of patients with diffuse large B-cell lymphoma
    Moller, MB
    Pedersen, NT
    Christensen, BE
    [J]. CANCER, 2006, 106 (10) : 2165 - 2170
  • [6] Predictors of delay in diagnosis and treatment in diffuse large B-cell lymphoma and impact on survival
    Nikonova, Anna
    Guirguis, Hany R.
    Buckstein, Rena
    Cheung, Matthew C.
    [J]. BRITISH JOURNAL OF HAEMATOLOGY, 2015, 168 (04) : 492 - 500
  • [7] THE IMPACT OF COMORBIDITY BURDEN ON THE OVERALL SURVIVAL IN PATIENTS WITH DIFFUSE LARGE B-CELL LYMPHOMA
    Andjelic, B.
    Antic, D.
    Nikolic, V.
    Popovic, L.
    Vukovic, V.
    Mihaljevic, B.
    [J]. HAEMATOLOGICA, 2012, 97 : 664 - 665
  • [8] Tafasitamab for the treatment of patients with diffuse large B-cell lymphoma
    Pirosa, Maria Cristina
    Stathis, Anastasios
    Zucca, Emanuele
    [J]. HUMAN VACCINES & IMMUNOTHERAPEUTICS, 2024, 20 (01)
  • [9] Treatment strategies for patients with diffuse large B-cell lymphoma
    Poletto, Stefano
    Novo, Mattia
    Paruzzo, Luca
    Frascione, Pio Manlio Mirko
    Vitolo, Umberto
    [J]. CANCER TREATMENT REVIEWS, 2022, 110
  • [10] Treatment of elderly patients with diffuse large B-cell lymphoma
    Nösslinger T.
    [J]. memo - Magazine of European Medical Oncology, 2016, 9 (1) : 8 - 12
12345